欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号SE/H/2354/006
药品名称Paliperidone STADA
活性成分
    • paliperidone palmitate 150.0 mg
    • paliperidone palmitate 100.0 mg
剂型Prolonged-release suspension for injection
上市许可持有人STADA Arzneimittel AG Stadastrasse 2-18 61118 Bad Vilbel Germany
参考成员国 - 产品名称Sweden (SE)
互认成员国 - 产品名称
    • Luxembourg (LU)
    • Austria (AT)
    • France (FR)
    • Italy (IT)
    • Hungary (HU)
      Paliperidon Palmiate Stada 150 mg és Paliperidon Palmiate Stada 100 mg mg retard szuszenziós injekció
    • Slovakia (SK)
    • Germany (DE)
    • Belgium (BE)
      Paliperidon EG 150 mg + 100 mg suspensie voor injectie met verlengde afgifte in een voorgevulde spuit
    • Netherlands (NL)
许可日期2024/03/14
最近更新日期2024/04/25
药物ATC编码
    • N05AX13 paliperidone
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Additional Strength/Form
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase